Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | Snx18 | Rat | 2,2',4,4'-Tetrabromodiphenyl ether | decreases expression | ISO | SNX18 (Homo sapiens) | 6480464 | 2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of SNX18 protein | CTD | PMID:31675489 | Snx18 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | Snx18 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of SNX18 mRNA | CTD | PMID:19933214 | Snx18 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of SNX18 mRNA | CTD | PMID:33387578 | Snx18 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of SNX18 mRNA | CTD | PMID:34747641 | Snx18 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Snx18 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of SNX18 mRNA | CTD | PMID:21570461 | Snx18 | Rat | 2,4,6-tribromophenol | decreases expression | ISO | SNX18 (Homo sapiens) | 6480464 | 2,4,6-tribromophenol results in decreased expression of SNX18 mRNA | CTD | PMID:31675489 | Snx18 | Rat | 3,3',5,5'-tetrabromobisphenol A | decreases expression | ISO | SNX18 (Homo sapiens) | 6480464 | tetrabromobisphenol A results in decreased expression of SNX18 protein | CTD | PMID:31675489 | Snx18 | Rat | acrolein | multiple interactions | ISO | SNX18 (Homo sapiens) | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of more ... | CTD | PMID:32699268 | Snx18 | Rat | aflatoxin B1 | decreases methylation | ISO | SNX18 (Homo sapiens) | 6480464 | Aflatoxin B1 results in decreased methylation of SNX18 gene | CTD | PMID:27153756 | Snx18 | Rat | alpha-pinene | multiple interactions | ISO | SNX18 (Homo sapiens) | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of more ... | CTD | PMID:32699268 | Snx18 | Rat | amiodarone | increases expression | ISO | SNX18 (Homo sapiens) | 6480464 | Amiodarone results in increased expression of SNX18 mRNA | CTD | PMID:19774075 | Snx18 | Rat | amphetamine | increases expression | EXP | | 6480464 | Amphetamine results in increased expression of SNX18 mRNA | CTD | PMID:30779732 | Snx18 | Rat | benzo[a]pyrene | increases expression | ISO | Snx18 (Mus musculus) | 6480464 | Benzo(a)pyrene results in increased expression of SNX18 mRNA | CTD | PMID:22228805 | Snx18 | Rat | benzo[a]pyrene | affects methylation | ISO | SNX18 (Homo sapiens) | 6480464 | Benzo(a)pyrene affects the methylation of SNX18 exon; Benzo(a)pyrene affects the methylation of SNX18 promoter | CTD | PMID:27901495 | Snx18 | Rat | bis(2-ethylhexyl) phthalate | affects expression | ISO | Snx18 (Mus musculus) | 6480464 | Diethylhexyl Phthalate affects the expression of SNX18 mRNA; Diethylhexyl Phthalate affects the expression of SNX18 more ... | CTD | PMID:37734331 | Snx18 | Rat | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of SNX18 mRNA | CTD | PMID:25181051|PMID:30816183|PMID:32528016|PMID:34947998 | Snx18 | Rat | bisphenol A | decreases expression | ISO | SNX18 (Homo sapiens) | 6480464 | bisphenol A results in decreased expression of SNX18 protein | CTD | PMID:31675489 | Snx18 | Rat | bisphenol A | decreases methylation | ISO | Snx18 (Mus musculus) | 6480464 | bisphenol A results in decreased methylation of SNX18 promoter | CTD | PMID:27312807 | Snx18 | Rat | bisphenol AF | increases expression | ISO | SNX18 (Homo sapiens) | 6480464 | bisphenol AF results in increased expression of SNX18 protein | CTD | PMID:34186270 | Snx18 | Rat | Butylbenzyl phthalate | increases methylation | ISO | Snx18 (Mus musculus) | 6480464 | butylbenzyl phthalate results in increased methylation of SNX18 intron | CTD | PMID:28392331 | Snx18 | Rat | cadmium atom | multiple interactions | ISO | Snx18 (Mus musculus) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of SNX18 more ... | CTD | PMID:37236586 | Snx18 | Rat | cadmium dichloride | decreases expression | ISO | SNX18 (Homo sapiens) | 6480464 | Cadmium Chloride results in decreased expression of SNX18 mRNA | CTD | PMID:38568856 | Snx18 | Rat | cadmium dichloride | multiple interactions | ISO | Snx18 (Mus musculus) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of SNX18 more ... | CTD | PMID:37236586 | Snx18 | Rat | calcitriol | increases expression | ISO | SNX18 (Homo sapiens) | 6480464 | Calcitriol results in increased expression of SNX18 mRNA | CTD | PMID:16002434 | Snx18 | Rat | chlorpyrifos | increases expression | ISO | Snx18 (Mus musculus) | 6480464 | Chlorpyrifos results in increased expression of SNX18 mRNA | CTD | PMID:37019170 | Snx18 | Rat | Cuprizon | increases expression | EXP | | 6480464 | Cuprizone results in increased expression of SNX18 mRNA | CTD | PMID:27523638 | Snx18 | Rat | decabromodiphenyl ether | decreases expression | ISO | SNX18 (Homo sapiens) | 6480464 | decabromobiphenyl ether results in decreased expression of SNX18 protein | CTD | PMID:31675489 | Snx18 | Rat | dibutyl phthalate | increases expression | EXP | | 6480464 | Dibutyl Phthalate results in increased expression of SNX18 mRNA | CTD | PMID:21266533 | Snx18 | Rat | dorsomorphin | multiple interactions | ISO | SNX18 (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased more ... | CTD | PMID:27188386 | Snx18 | Rat | fenvalerate | increases expression | EXP | | 6480464 | fenvalerate results in increased expression of SNX18 mRNA | CTD | PMID:30307764 | Snx18 | Rat | flutamide | increases expression | EXP | | 6480464 | Flutamide results in increased expression of SNX18 mRNA | CTD | PMID:24136188 | Snx18 | Rat | FR900359 | decreases phosphorylation | ISO | SNX18 (Homo sapiens) | 6480464 | FR900359 results in decreased phosphorylation of SNX18 protein | CTD | PMID:37730182 | Snx18 | Rat | inulin | multiple interactions | ISO | Snx18 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of SNX18 mRNA | CTD | PMID:36331819 | Snx18 | Rat | irinotecan | decreases expression | ISO | SNX18 (Homo sapiens) | 6480464 | Irinotecan metabolite results in decreased expression of SNX18 mRNA; Irinotecan results in decreased expression of more ... | CTD | PMID:15956246 | Snx18 | Rat | ketoconazole | increases expression | ISO | SNX18 (Homo sapiens) | 6480464 | Ketoconazole results in increased expression of SNX18 mRNA | CTD | PMID:36621641 | Snx18 | Rat | lipopolysaccharide | decreases expression | ISO | SNX18 (Homo sapiens) | 6480464 | Lipopolysaccharides results in decreased expression of SNX18 mRNA | CTD | PMID:35811015 | Snx18 | Rat | lipopolysaccharide | multiple interactions | ISO | SNX18 (Homo sapiens) | 6480464 | [S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of SNX18 mRNA | CTD | PMID:35811015 | Snx18 | Rat | methotrexate | increases expression | ISO | SNX18 (Homo sapiens) | 6480464 | Methotrexate results in increased expression of SNX18 mRNA | CTD | PMID:24449571 | Snx18 | Rat | methoxychlor | affects methylation | EXP | | 6480464 | Methoxychlor affects the methylation of SNX18 gene | CTD | PMID:35440735 | Snx18 | Rat | oxaliplatin | multiple interactions | EXP | | 6480464 | [oxaliplatin co-treated with Topotecan] results in increased expression of SNX18 mRNA | CTD | PMID:25729387 | Snx18 | Rat | ozone | multiple interactions | ISO | SNX18 (Homo sapiens) | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of more ... | CTD | PMID:32699268 | Snx18 | Rat | ozone | multiple interactions | ISO | Snx18 (Mus musculus) | 6480464 | [Air Pollutants results in increased abundance of Ozone] which results in increased expression of SNX18 more ... | CTD | PMID:34911549 | Snx18 | Rat | paracetamol | affects expression | EXP | | 6480464 | Acetaminophen affects the expression of SNX18 mRNA | CTD | PMID:17984051 | Snx18 | Rat | paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of SNX18 mRNA | CTD | PMID:33387578 | Snx18 | Rat | paracetamol | decreases expression | ISO | SNX18 (Homo sapiens) | 6480464 | Acetaminophen results in decreased expression of SNX18 mRNA | CTD | PMID:22230336 | Snx18 | Rat | paracetamol | affects expression | ISO | Snx18 (Mus musculus) | 6480464 | Acetaminophen affects the expression of SNX18 mRNA | CTD | PMID:17562736 | Snx18 | Rat | perfluorooctane-1-sulfonic acid | multiple interactions | ISO | Snx18 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of SNX18 mRNA | CTD | PMID:36331819 | Snx18 | Rat | phenobarbital | affects expression | ISO | Snx18 (Mus musculus) | 6480464 | Phenobarbital affects the expression of SNX18 mRNA | CTD | PMID:23091169 | Snx18 | Rat | phenylmercury acetate | increases expression | ISO | SNX18 (Homo sapiens) | 6480464 | Phenylmercuric Acetate results in increased expression of SNX18 mRNA | CTD | PMID:26272509 | Snx18 | Rat | phenylmercury acetate | multiple interactions | ISO | SNX18 (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased more ... | CTD | PMID:27188386 | Snx18 | Rat | resveratrol | increases expression | ISO | SNX18 (Homo sapiens) | 6480464 | resveratrol results in increased expression of SNX18 mRNA | CTD | PMID:25888808 | Snx18 | Rat | rotenone | decreases expression | ISO | SNX18 (Homo sapiens) | 6480464 | Rotenone results in decreased expression of SNX18 protein | CTD | PMID:39603559 | Snx18 | Rat | S-(1,2-dichlorovinyl)-L-cysteine | multiple interactions | ISO | SNX18 (Homo sapiens) | 6480464 | [S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of SNX18 mRNA | CTD | PMID:35811015 | Snx18 | Rat | SB 431542 | multiple interactions | ISO | SNX18 (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased more ... | CTD | PMID:27188386 | Snx18 | Rat | sodium arsenate | decreases expression | ISO | Snx18 (Mus musculus) | 6480464 | sodium arsenate results in decreased expression of SNX18 mRNA | CTD | PMID:39847705 | Snx18 | Rat | sodium arsenite | decreases expression | ISO | SNX18 (Homo sapiens) | 6480464 | sodium arsenite results in decreased expression of SNX18 protein | CTD | PMID:30528433 | Snx18 | Rat | sodium arsenite | decreases methylation | ISO | Snx18 (Mus musculus) | 6480464 | sodium arsenite results in decreased methylation of SNX18 gene | CTD | PMID:39894169 | Snx18 | Rat | Soman | increases expression | EXP | | 6480464 | Soman results in increased expression of SNX18 mRNA | CTD | PMID:19281266 | Snx18 | Rat | tetrachloromethane | affects expression | ISO | Snx18 (Mus musculus) | 6480464 | Carbon Tetrachloride affects the expression of SNX18 mRNA | CTD | PMID:17484886 | Snx18 | Rat | tetrachloromethane | increases expression | ISO | Snx18 (Mus musculus) | 6480464 | Carbon Tetrachloride results in increased expression of SNX18 mRNA | CTD | PMID:31919559 | Snx18 | Rat | thioacetamide | increases expression | EXP | | 6480464 | Thioacetamide results in increased expression of SNX18 mRNA | CTD | PMID:34492290 | Snx18 | Rat | titanium dioxide | decreases methylation | ISO | Snx18 (Mus musculus) | 6480464 | titanium dioxide results in decreased methylation of SNX18 gene | CTD | PMID:35295148 | Snx18 | Rat | topotecan | multiple interactions | EXP | | 6480464 | [oxaliplatin co-treated with Topotecan] results in increased expression of SNX18 mRNA | CTD | PMID:25729387 | Snx18 | Rat | topotecan | increases expression | EXP | | 6480464 | Topotecan results in increased expression of SNX18 mRNA | CTD | PMID:25729387 | Snx18 | Rat | trichostatin A | increases expression | ISO | SNX18 (Homo sapiens) | 6480464 | trichostatin A results in increased expression of SNX18 mRNA | CTD | PMID:26272509 | Snx18 | Rat | trichostatin A | multiple interactions | ISO | SNX18 (Homo sapiens) | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased more ... | CTD | PMID:27188386 | Snx18 | Rat | tungsten | decreases expression | ISO | Snx18 (Mus musculus) | 6480464 | Tungsten results in decreased expression of SNX18 mRNA | CTD | PMID:30912803 | Snx18 | Rat | valproic acid | affects expression | ISO | Snx18 (Mus musculus) | 6480464 | Valproic Acid affects the expression of SNX18 mRNA | CTD | PMID:17963808 | Snx18 | Rat | valproic acid | increases methylation | ISO | SNX18 (Homo sapiens) | 6480464 | Valproic Acid results in increased methylation of SNX18 gene | CTD | PMID:29154799 | Snx18 | Rat | valproic acid | increases expression | ISO | SNX18 (Homo sapiens) | 6480464 | Valproic Acid results in increased expression of SNX18 mRNA | CTD | PMID:23179753|PMID:26272509|PMID:29154799 | Snx18 | Rat | valproic acid | multiple interactions | ISO | SNX18 (Homo sapiens) | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased more ... | CTD | PMID:27188386 | | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||






















